Reported data on vaccines may not build public trust or adherence

June 01, 2016

COLUMBIA, Mo. - The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety reporting system that collects information about possible side effects that may occur after inoculation. Developed by the Centers for Disease Control (CDC) and available online, anyone can report possible adverse reactions to vaccines for any reason, making it a rich source of information about possible vaccine harms. Recently, University of Missouri researchers proposed that open communication about VAERS could improve public trust that vaccines are safe, thereby increasing vaccine acceptance. Findings from the study suggest that data and stories may not increase the public's acceptance of vaccines.

"One of the issues in vaccine acceptance is trust," said Laura Scherer, associate professor of psychological sciences in the MU College of Arts and Science. "Individuals, parents and vaccine opponents lack trust that doctors and the government have done sufficient research to validate the safety of vaccines. By educating participants about the VAERS system, we thought that this might increase trust that the Centers for Disease Control are doing everything that they can to research and document vaccine harms."

Using data on serious adverse events reported for the Human Papillomavirus vaccine in VAERS in 2013, the researchers surveyed more than 1,200 participants' reactions to the VAERS reports. The first group was presented with the standard HPV vaccine statement that all patients receive prior to vaccination. The second group was given the same vaccine statement as well as information about VAERS, which included data showing that out of approximately 10 million vaccinations, 24 individuals were reported to have been disabled and seven were reported to possibly have died as a result of their vaccinations. The third group received this VAERS information and also read the detailed reports of each event.

"Since anyone can report anything to VAERS for any reason, the VAERS reports contain incidents of serious adverse events that may not have anything to do with the vaccine," Scherer said. "We thought that by having people read the actual reports, they would see that there are very few reported serious events, and that the vaccine may not have even caused the event. Taken together, we felt this might make participants feel more assured that vaccines are safe -- but in fact, what we found was the opposite."

Results showed that participants who were educated about the VAERS system and who were given summary data about adverse events had slightly more vaccine acceptance compared to those who received the vaccine statement alone. However, exposure to detailed incident reports significantly reduced vaccine acceptance and trust in the CDC's declaration that vaccines are safe.

"When participants read the incident reports, there was a marked reduction in their willingness to vaccinate -- even though most participants believed the vaccines caused few or even none of the deaths," Scherer said. "Stories about vaccine harms can influence vaccine acceptance even when people don't completely believe them. This can potentially inform how people react to stories versus data about vaccine harms and provides a test of publicly available data on vaccine acceptance. It also means that the media should be very careful about propagating stories about vaccine harms when it is unclear that the vaccine was the cause."

The study, "Can the vaccine adverse event reporting system be used to increase vaccine acceptance and trust?" recently was published in the journal Vaccine. Scherer co-authored the study with Victoria Shaffer, associate professor of psychological sciences at MU and an assistant professor of health sciences in the MU School of Health Professions.
-end-


University of Missouri-Columbia

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.